Verve Therapeutics
Verve Therapeutics develops genetic medicines that target cardiovascular diseases through innovative therapies. The company focuses on creating treatments that address the genetic causes of these conditions, aiming to transform how cardiovascular diseases are managed. As a clinical-stage organization, Verve is engaged in advancing its product candidates through rigorous research and development processes. The company emphasizes its commitment to improving patient outcomes by leveraging genetic insights to develop effective solutions. Verve Therapeutics continues to evolve in the field of genetic medicine, contributing to the future of cardiovascular health.
Domain
vervetx.com
Country
United StatesIndustry
BiotechnologyEmployees
251-500
Last Funding
$143.8M
Founded
2017
Tech Stack (10 technologies)
Frequently Asked Questions
What technologies does Verve Therapeutics use?+
Verve Therapeutics uses 10 technologies including Cookiebot, Drupal, Google Tag Manager.
What industry is Verve Therapeutics in?+
Verve Therapeutics operates in the Biotechnology industry.
Where is Verve Therapeutics based?+
Verve Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026